ClinicalTrials.gg
CompletedNCT07677020Updated Jun 30, 2026

Anorexia Prevention in Female College Students

An interventional study of Acceptance-Based Embodied Movement and Functional Fitness Control in Eating Disorder Risk and Body Shape Concern, sponsored by Jinan University Guangzhou. Completed at 1 site in China. Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Jinan University Guangzhou · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jun 2025, registered Jun 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
135
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Study summary

This study evaluated whether an acceptance-based embodied movement program can reduce eating disorder risk and body shape concerns in female college students at elevated risk. A total of 135 female undergraduate and graduate students were randomly assigned to one of three groups: acceptance-based embodied movement, functional fitness control, or psychoeducation. The intervention lasted 8 weeks, and outcomes were assessed at baseline, week 4, week 8, and 3-month follow-up. The main outcomes were eating disorder risk and body shape concern. Secondary outcomes included depression, anxiety, body image flexibility, functionality appreciation, and body surveillance.

Read the detailed description

This was a single-blind, three-arm, parallel-group randomized controlled trial conducted among female college students at elevated risk of eating disorders or body shape concerns. Participants were recruited from Jinan University and randomly assigned in a 1:1:1 ratio to acceptance-based embodied movement, functional fitness control, or psychoeducation.

The acceptance-based embodied movement program used low-impact mindful movements derived from yoga and tai chi and incorporated acceptance and commitment therapy techniques. The program emphasized present-moment body sensations, acceptance of appearance-related thoughts and feelings, cognitive defusion, valued action, and appreciation of body functionality. The functional fitness control program matched the movement intervention in session duration, frequency, and contact time, but removed mindfulness and acceptance components. It included aerobic and core exercises with standard fitness instruction. The psychoeducation program provided cognitive and dissonance-based body image education without physical activity.

All three programs lasted 8 weeks and were delivered in groups by trained facilitators using written manuals. Outcomes were assessed at baseline, mid-intervention, post-intervention, and 3-month follow-up. The primary outcomes were eating disorder risk measured by the Eating Disorder Examination Questionnaire Short Form and body shape concern measured by the Body Shape Questionnaire-8C. Secondary outcomes included depression, anxiety, body image flexibility, functionality appreciation, and body surveillance. Attendance, intervention fidelity, and adverse events were monitored throughout the study.

02

Conditions studied

  • Eating Disorder Risk
  • Body Shape Concern

Keywords

  • Female college students
  • Disordered eating
  • Body image
  • Body image flexibility
  • Embodied movement
  • Acceptance and commitment therapy
  • Functionality appreciation
03

In context

Lead sponsor

Jinan University Guangzhou is the lead sponsor of 14 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female undergraduate or graduate students.
  • Aged 18 to 25 years.
  • Elevated eating disorder risk or body shape concern based on the prespecified screening threshold.
  • Physically able to participate in light-intensity physical activity.
  • Provided written .

Exclusion criteria

Exclusion Criteria:

  • Current treatment for an eating disorder.
  • Any physical condition contraindicating participation in exercise.
  • Pregnancy.
  • Concurrent participation in another structured body image or exercise program.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
135 participants (actual)

Study arms

  • Experimental
    Acceptance-Based Embodied Movement

    Participants received an 8-week acceptance-based embodied movement program delivered in groups. The program used low-impact mindful movements derived from yoga and tai chi and incorporated acceptance and commitment therapy techniques, including present-moment awareness, acceptance of appearance-related thoughts and feelings, cognitive defusion, valued action, and appreciation of body functionality.

    Behavioral: Acceptance-Based Embodied Movement

  • Active comparator
    Functional Fitness Control

    Participants received an 8-week functional fitness control program delivered in groups. This program matched the embodied movement program in session duration, frequency, and contact time, but removed mindfulness and acceptance components. It included aerobic and core exercises with standard fitness instruction focused on exertion, completion of exercises, and cardiorespiratory fitness.

    Behavioral: Functional Fitness Control

  • Active comparator
    Psychoeducation

    Participants received an 8-week psychoeducation program delivered in groups without physical activity. The program provided cognitive and dissonance-based body image education, including critical discussion of idealized media images, appearance-focused talk, and body-related self-esteem.

    Behavioral: Psychoeducation

Interventions

  • BehavioralAcceptance-Based Embodied Movement

    An 8-week group-based embodied movement program using low-impact mindful movements derived from yoga and tai chi. The program incorporated acceptance and commitment therapy techniques, including present-moment body awareness, acceptance of appearance-related thoughts and feelings, cognitive defusion, valued action, and appreciation of body functionality.

  • BehavioralFunctional Fitness Control

    An 8-week group-based functional fitness program matched to the embodied movement program in session duration, frequency, and contact time. The program included aerobic and core exercises with standard fitness instruction and did not include mindfulness, acceptance, or body-image-focused guidance.

  • BehavioralPsychoeducation

    An 8-week group-based psychoeducation program without physical activity. The program provided cognitive and dissonance-based body image education, including critical discussion of idealized media images, appearance-focused talk, and body-related self-esteem.

06

What researchers measure

Primary outcomes

  1. Eating Disorder Risk

    Eating disorder risk was measured using the Eating Disorder Examination Questionnaire Short Form (EDE-QS). Higher scores indicate greater eating disorder risk.

    Time frame: Baseline, week 4, week 8, and week 20 follow-up

  2. Body Shape Concern

    Body shape concern was measured using the 8-item Body Shape Questionnaire (BSQ-8C). Higher scores indicate greater body shape concern.

    Time frame: Baseline, week 4, week 8, and week 20 follow-up

Secondary outcomes

  1. Depressive Symptoms

    Depressive symptoms were measured using the 9-item Patient Health Questionnaire (PHQ-9). Higher scores indicate more severe depressive symptoms.

    Time frame: Baseline, week 4, week 8, and week 20 follow-up

  2. Anxiety Symptoms

    Anxiety symptoms were measured using the 7-item Generalized Anxiety Disorder scale (GAD-7). Higher scores indicate more severe anxiety symptoms.

    Time frame: Baseline, week 4, week 8, and week 20 follow-up

  3. Body Image Flexibility

    Body image flexibility was measured using the Body Image Acceptance and Action Questionnaire (BI-AAQ). Higher scores indicate greater body image flexibility.

    Time frame: Baseline, week 4, week 8, and week 20 follow-up

  4. Functionality Appreciation

    Functionality appreciation was measured using the Functionality Appreciation Scale (FAS). Higher scores indicate greater appreciation of body functionality.

    Time frame: Baseline, week 4, week 8, and week 20 follow-up

07

Study locations

1 site
  • Jinan University
    Guangzhou, Gaungdong, China
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because participant consent and ethics approval did not include a plan for public sharing of individual-level data.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2025 to primary completion in Dec 2025, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2026
First posted
Jun 30, 2026
StartActual
Jun 1, 2025
Primary completionActual
Dec 1, 2025
CompletionActual
Dec 1, 2025
Last update
Jun 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07677020
Lead sponsor
Jinan University Guangzhou
Responsible party
Xiaoma (Master's advisor, Jinan University Guangzhou) — Principal investigator
First posted
Jun 30, 2026
Start date
Jun 1, 2025
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025
Last update
Jun 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion